- Home
- OSUR vs DSM Comparison
OSUR vs DSM Comparison
Compare OSUR & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- DSM
- Stock Information
- Founded
- OSUR 2000
- DSM 1989
- Country
- OSUR United States
- DSM United States
- Employees
- OSUR N/A
- DSM N/A
- Industry
- OSUR Medical/Dental Instruments
- DSM Investment Managers
- Sector
- OSUR Health Care
- DSM Finance
- Exchange
- OSUR Nasdaq
- DSM Nasdaq
- Market Cap
- OSUR 266.7M
- DSM 289.7M
- IPO Year
- OSUR 1986
- DSM N/A
- Fundamental
- Price
- OSUR $3.44
- DSM $5.88
- Analyst Decision
- OSUR Hold
- DSM
- Analyst Count
- OSUR 2
- DSM 0
- Target Price
- OSUR $5.50
- DSM N/A
- AVG Volume (30 Days)
- OSUR 1.0M
- DSM 161.7K
- Earning Date
- OSUR 05-07-2025
- DSM 01-01-0001
- Dividend Yield
- OSUR N/A
- DSM 3.97%
- EPS Growth
- OSUR N/A
- DSM N/A
- EPS
- OSUR N/A
- DSM N/A
- Revenue
- OSUR $185,827,000.00
- DSM N/A
- Revenue This Year
- OSUR N/A
- DSM N/A
- Revenue Next Year
- OSUR $8.41
- DSM N/A
- P/E Ratio
- OSUR N/A
- DSM N/A
- Revenue Growth
- OSUR N/A
- DSM N/A
- 52 Week Low
- OSUR $2.69
- DSM $4.69
- 52 Week High
- OSUR $6.69
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- OSUR 45.82
- DSM 31.77
- Support Level
- OSUR $3.40
- DSM $6.01
- Resistance Level
- OSUR $3.55
- DSM $6.10
- Average True Range (ATR)
- OSUR 0.15
- DSM 0.05
- MACD
- OSUR 0.02
- DSM -0.03
- Stochastic Oscillator
- OSUR 56.52
- DSM 7.14
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.